NASDAQ
Appili Therapeutics Inc. (APLIF) has a free cash flow growth of 61.44% as of Friday, May 29, 2026. This represents a 102.08% increase compared to its 12-month average of -2955.84%. Free cash flow growth tracks the year-over-year percentage change in cash generated after capital expenditures.
No price data available for this timeframe.